Abstract
Coronary artery disease and metabolic syndrome together are two major causes of death in the United States and the numbers of people afflicted by these diseases are increasing around the world. Overactivation of calpain has been shown to contribute to cardiovascular disease and its associated comorbidities. Therefore, calpain inhibition may offer a novel potential medical therapy for treating not only coronary artery disease but also the individual aspects of the associated comorbidities.
| Original language | English (US) |
|---|---|
| Title of host publication | Proteases in Human Diseases |
| Publisher | Springer Singapore |
| Pages | 411-423 |
| Number of pages | 13 |
| ISBN (Electronic) | 9789811031625 |
| ISBN (Print) | 9789811031618 |
| DOIs | |
| State | Published - Jul 13 2017 |
All Science Journal Classification (ASJC) codes
- General Social Sciences
- General Economics, Econometrics and Finance
- General Business, Management and Accounting